Search results for "CIRRHOSIS"

showing 10 items of 964 documents

Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study

2018

BACKGROUND Cirrhosis is associated with morpho-functional cardiovascular alterations. AIMS To detect early features of cardiovascular damage in HCV-compensated cirrhotic patients using myocardial deformation indices and carotid arterial stiffness, and, further, to evaluate their short-term behaviour after HCV eradication with direct antiviral agents (DAAs). METHODS Thirty-nine consecutive patients with HCV cirrhosis, without previous cardiovascular events, were studied and matched for age, gender and cardiovascular risk factors to 39 controls without liver or cardiovascular disease. Patients and controls underwent a baseline echocardiographic evaluation including global longitudinal strain …

medicine.medical_specialtyCirrhosisSettore MED/09 - Medicina InternaHepatologybusiness.industryGastroenterologyHepatitis C030204 cardiovascular system & hematologycardiovascular damage cirrhosis HCV global longitudinal strainmedicine.disease03 medical and health sciencesLiver disease0302 clinical medicineInternal medicineDiabetes mellitusArterial stiffnessCardiologyMedicine030211 gastroenterology & hepatologyPharmacology (medical)businessProspective cohort studyPulse wave velocitySubclinical infection
researchProduct

Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience.

2008

Abstract Background Intrahepatic cholangiocarcinoma (ICC) is not a widely accepted indication for orthotopic liver transplantation (OLT). The present study describes our institutional experience with patients who underwent transplantation for ICC as well as those with ICC who underwent transplantation with the incorrect diagnosis of hepatocellular carcinoma (HCC). Patients and Methods Data corresponding to ICC patients were reviewed for the purposes of this study. Patients with hilar cholangiocarcinoma and incidentally found ICC after OLT for benign diseases were excluded from further consideration. Results Among the 10 patients, 6 underwent transplantation before 1996 and 4 after 2001. Tho…

medicine.medical_specialtyCirrhosisTime Factorsmedicine.medical_treatmentMedizinLiver transplantationMilan criteriaGastroenterologyPrimary sclerosing cholangitisCholangiocarcinomaInternal medicinemedicineHepatectomyHumansHospital MortalitySurvivorsSurvival rateIntrahepatic CholangiocarcinomaRetrospective StudiesTransplantationbusiness.industrymedicine.diseaseSurgeryLiver TransplantationTransplantationSurvival Ratesurgical procedures operativeBile Ducts IntrahepaticBile Duct NeoplasmsSurgeryHepatectomybusinessFollow-Up StudiesTransplantation proceedings
researchProduct

Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany

2018

BACKGROUND Advanced fibrosis has been established as the most important predictor of overall mortality in patients with non-alcoholic fatty liver disease (NAFLD). In contrast to cirrhosis, advanced, non-cirrhotic NAFLD is difficult to identify and data from Germany are lacking. AIM To identify clinical factors associated with advanced, non-cirrhotic fibrosis. METHODS Patients were recruited in the prospectively enrolling European NAFLD Registry. Clinical characteristics and the performance of non-invasive surrogate scores compared with vibration-controlled transient elastography are reported. RESULTS Two hundred and sixty-one patients with non-cirrhotic NAFLD on liver biopsy (mean age 51 ye…

medicine.medical_specialtyCirrhosisType 2 diabetesGastroenterology03 medical and health sciences0302 clinical medicineFibrosisInternal medicineDiabetes mellitusmedicinePharmacology (medical)10. No inequality2. Zero hungerHepatologymedicine.diagnostic_testbusiness.industryFatty liverGastroenterologymedicine.disease3. Good health030220 oncology & carcinogenesisLiver biopsy030211 gastroenterology & hepatologybusinessTransient elastographyBody mass indexAlimentary Pharmacology & Therapeutics
researchProduct

Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?

2017

Background In the absence of liver biopsy, the World Health Organization recommends non-invasive tests, such as aspartate aminotransferase to platelet ratio index and FIB-4, to assess liver fibrosis in patients with chronic hepatitis B. However, these tests are not well validated in sub-Saharan Africa. Recently, a new marker, gamma-glutamyl transpeptidase to platelet ratio, was found to be more accurate in an African setting, but this needs confirmation in other cohorts. Methods A treatment program for chronic hepatitis B was initiated in Addis Ababa, Ethiopia, in 2015. Non-invasive tests were compared with transient elastography (Fibroscan 402, Echosense, France) using the following thresh…

medicine.medical_specialtyCirrhosisViral Hepatitismedicine.disease_causeGastroenterology03 medical and health sciences0302 clinical medicineFibrosisInternal medicinemedicineGamma-glutamyltransferaseliver fibrosisHepatitis B virusHepatologyReceiver operating characteristicmedicine.diagnostic_testbiologybusiness.industrynon‐invasive testsmedicine.disease030220 oncology & carcinogenesisLiver biopsyPredictive value of testsbiology.proteinOriginal Article030211 gastroenterology & hepatologybusinessTransient elastographyhepatitis B virussub‐Saharan AfricaLiver International
researchProduct

Ver�nderungen an Proteinen der Leber und des Blutes bei experimenteller Lebercirrhose und nach Behandlung mit Decortin und einem anabolen Steroid

1963

medicine.medical_specialtyCirrhosisbiologyChemistrymedicine.medical_treatmentGeneral MedicineMitochondrionmedicine.diseaseFibrinogenMolecular medicineBlood proteinsEndocrinologyNandroloneInternal medicineDrug Discoverymedicinebiology.proteinMolecular MedicineCeruloplasminGenetics (clinical)Anabolic steroidmedicine.drugKlinische Wochenschrift
researchProduct

Response of patients with chronic Hepatitis B in one year of treatment with Major Autohemotherapy.

2018

The Hepatitis B (HVB) is one of the most common infectious diseases in the world, it’s wide geographical distribution is a health problem, especially on the African continent, with prevalence rate of 6.1% in the adult population. Current treatment requires prolonged therapy (most cases for the rest of life) with the aim of stopping viral replication, maintaining immunological stability, preventing progression of liver disease and the most feared complications such as cirrhosis and hepatic cancer
 There are multiple references that point to ozone therapy as an alternative in the treatment of Hepatitis B, because of the known and demonstrated antimicrobial and immunomodulatory properties…

medicine.medical_specialtyCirrhosisbiologybusiness.industryHepatitis B:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseOzone therapyGastroenterologyAutohemotherapyLiver diseaseAntigenInternal medicineUNESCO::CIENCIAS MÉDICASmedicinebiology.proteinAntibodybusinessViral loadJournal of Ozone Therapy
researchProduct

Duplexsonographische Untersuchungen zur Pathogenese der lienalen Hämodynamik bei Leberzirrhose

2008

AIM OF STUDY The haemodynamic role of the spleen in portal hypertension remains unclear. Duplex sonography was undertaken prospectively to discover the relationship of splenomegaly and splenic vein flow to type and severity of liver cirrhosis and portal vein flow, as well as to the degree of oesophageal varices. PATIENTS AND METHODS 89 patients (54 men, 35 women; mean age 52 [26-81] years), diagnosed in the second half of 1993 as having liver cirrhosis were consecutively included in the study. In 40 patients the cirrhosis was in stage A (according to Child-Pugh classification), in 31 in stage B and in 18 in stage C. RESULTS Portal vein flow fell significantly with increasing degree of cirrh…

medicine.medical_specialtyCirrhosisbusiness.industryHemodynamicsSpleenGeneral Medicinemedicine.diseaseGastroenterologyPathophysiologymedicine.anatomical_structureSplenic veinInternal medicinemedicinePortal hypertensionStage (cooking)VaricesbusinessDMW - Deutsche Medizinische Wochenschrift
researchProduct

C4BQO in familial clustering of liver cirrhosis

1993

medicine.medical_specialtyCirrhosisbusiness.industryInternal medicineImmunologymedicineFamilial clusteringmedicine.diseasebusinessMolecular BiologyGastroenterologyMolecular Immunology
researchProduct

The Clinical Course of Portal Hypertension in Liver Cirrhosis

2000

Portal hypertension is caused by liver cirrhosis in almost %% of patients in Europe and in North America. Other causes such as hepato-splenic schistosomiasis, noncirrhotic portal fibrosis and extrahepatic portal vein thrombosis are more common in Asia and South America.

medicine.medical_specialtyCirrhosisbusiness.industryPortal venous pressurePortal hypertensive gastropathySchistosomiasismedicine.diseaseGastroenterologyPortal vein thrombosisEsophageal varicesInternal medicinePortal fibrosismedicinePortal hypertensionbusiness
researchProduct

A Cholestatic Pattern Predicts Liver-Related Events in Patients with Nonalcoholic Fatty Liver Disease

2021

Background & Aims: Liver test alteration patterns can be categorized as: predominantly hepatocellular(H), with an ALT/ALP ratio>5; predominantly cholestatic pattern(C) with a ratio 55 years(HR2.55,95%C.I.1.17-5.54;p=0.01), platelets<150,000/mmc(HR0.14,95%C.I.0.06-0.32;p<0.001), albumin<4g/L(HR0.62,95%C.I.0.35-1.08;p=0.09), C vs M pattern(HR7.86,95%C.I.1.03-60.1;p=0.04), C vs H pattern(HR12.1,95% C.I.1.61-90.9;p=0.01) and fibrosis F3-F4(HR35.8,95%C.I.4.65-275.2;p<0.001) were independent risk factors for LRE occurrence. C vs M pattern(HR14.3,95%C.I.1.90-105.6;p=0.008) and C vs H pattern(HR15.6,95%C.I. 2.10-115.1;p=0.0068) were confirmed independently associated with LRE occurrence in the vali…

medicine.medical_specialtyCirrhosisbusiness.industryProportional hazards modelmedicine.diseaseGastroenterologyLiver diseaseCholestasisMetaplasiaInternal medicineCohortNonalcoholic fatty liver diseaseMedicineIn patientmedicine.symptombusinessSSRN Electronic Journal
researchProduct